{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_017617.3:c.1309T>G",
          "cDNA Change": {
            "transcript": "NM_017617.3",
            "ref": "T",
            "alt": "G",
            "position": "1309"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "G",
            "position": "437"
          },
          "Description in input context": "homozygous mutation p.W437X in PINK1"
        }
      ]
    },
    {
      "Gene": "MT-ND5",
      "variants": [
        {
          "HGVS": "NC_012920.1:g.12397A>G",
          "cDNA Change": {
            "transcript": "NC_012920.1",
            "ref": "A",
            "alt": "G",
            "position": "12397"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "A",
            "position": "21"
          },
          "Description in input context": "missense mutation m.12397A>G (p.T21A) in MT-ND5"
        }
      ]
    },
    {
      "Gene": "MT-ND6",
      "variants": [
        {
          "HGVS": "NC_012920.1:g.14319T>C",
          "cDNA Change": {
            "transcript": "NC_012920.1",
            "ref": "T",
            "alt": "C",
            "position": "14319"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "D",
            "position": "119"
          },
          "Description in input context": "missense mutation m.14319T>C (p.N119D) in MT-ND6"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Early-onset Parkinsonism",
    "MONDO": "MONDO:0005321"
  },
  "Experiment Method": [
    {
      "Assay Method": "mtDNA Sequence Analysis",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient and mother fibroblasts",
        "Description": "Fibroblasts from the patient and their mother were analyzed for mtDNA mutations."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NC_012920.1:g.12397A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No Effect",
          "Result Description": "Homoplasmic mutation m.12397A>G (p.T21A) in MT-ND5."
        },
        {
          "Variant": "NC_012920.1:g.14319T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No Effect",
          "Result Description": "Homoplasmic mutation m.14319T>C (p.N119D) in MT-ND6."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No homoplasmic mutations detected in control samples.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of homoplasmic mutations in mtDNA.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Enzyme Kinetic Analysis of NADH:Ubiquinone Oxidoreductase",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient fibroblasts",
        "Description": "Enzyme kinetic analysis of NADH:ubiquinone oxidoreductase was performed on patient fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017617.3:c.1309T>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No Effect",
          "Result Description": "Changes in substrate affinity for NADH:ubiquinone oxidoreductase."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal substrate affinity within 10% of control values.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Substrate affinity deviation exceeding 20% from control values.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Superoxide Anion Radical Measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient fibroblasts",
        "Description": "Superoxide anion radical production was measured in patient fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017617.3:c.1309T>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No Effect",
          "Result Description": "Increased superoxide anion radical production, abrogated by complex I inhibitor."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal levels of superoxide anion radicals within 15% of control values.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Superoxide anion radical levels exceeding 30% of control values.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}